The City of Nice obtains the labeling of its vaccination center once morest monkey pox and increases its vaccination capacity as of today.
Since July 22, the City of Nice has opened a vaccination center once morest monkey pox, in perfect coordination with the University Hospital and the LGBTQIA+ Côte d’Azur Cegidd center, in order to streamline appointment requests and limit waiting time. Today, this municipal vaccination center has just been labeled by the Provence Alpes Côte d’Azur Regional Health Agency. The City of Nice and its Environmental Health Safety and Risk Management Agency are intensifying their efforts to enable all those eligible for vaccination to quickly find slots and protect themselves.
Christian Estrosi, Mayor of Nice, President of the Nice Côte d’Azur Metropolis: “The experience of the coronavirus has taught us a lot, in particular on the speed of implementation of vaccination in order to limit the spread of viruses. I obtained last week the guarantee of the Minister of Health of a resupply of doses as much as necessary on our territory. MEven if the two viruses are quite distinct, the vaccination campaign once morest monkeypox and its speed of execution are strategic to protect populations as quickly as possible. Thus, the vaccination capacity of the municipal vaccination center in rue Saint François de Paule is now increasing from 80 to 140 appointments per week”.
Vaccination only by appointment, on 04 97 13 56 00.
Mondays and Wednesdays, from 5:30 p.m. to 8 p.m. in the center of rue Saint François de Paule / rue Max Gallo;
Tuesday and Thursday mornings, from 8 a.m. to 10 a.m., in the center of rue Saint François de Paule / rue Max Gallo;
Fridays from 1 p.m. to 8 p.m., in partnership with the LGBTQIA+ Côte d’Azur center, at CeGIDD, 8 rue Baquis. Make an appointment on 04 89 04 55 60.
At the Nice University Hospital via the Doctolib site.
The vaccination schedule includes 2 doses 28 days apart (or 1 single dose for people who have already been vaccinated once morest smallpox (people over 45), and 3 doses for immunocompromised people.
